Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons

Brain Research

Volumn 1307, Issue , 2010, Pages 14-21

  Scheuch, Kathrin ^a   Höltje, Markus ^a   Budde, Holger ^a   Lautenschlager, Marion ^a   Heinz, Andreas ^a   Ahnert Hilger, Gudrun ^a   Priller, Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cell culture; Lithium; Serotonergic raphe neurons; Serotonin release; Serotonin uptake; Tryptophan hydroxylase 2

Indexed keywords

FLUOXETINE; LITHIUM; MESSENGER RNA; SEROTONIN; TRYPTOPHAN HYDROXYLASE 2;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL MEMBRANE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MODULATION; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEROTONIN RELEASE; SEROTONIN UPTAKE; SEROTONINERGIC NERVE CELL; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; FLUOXETINE; GENE EXPRESSION REGULATION; L-LACTATE DEHYDROGENASE; LITHIUM CHLORIDE; NEURONS; POTASSIUM; RAPHE NUCLEI; RATS; REGRESSION ANALYSIS; RNA, MESSENGER; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STREPTOLYSINS; TIME FACTORS; TRITIUM; TRYPTOPHAN HYDROXYLASE;

RATTUS;

EID: 70749090026     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.10.027     Document Type: Article

References (44)

1. Ahnert-Hilger G., Nürnberg B., Exner T., Schäfer T., and Jahn R. The heterotrimeric G protein Go2 regulates catecholamine uptake by secretory vesicles. EMBO J. 17 (1998) 406-413
2. Baptista T.J., Hernández L., Burguera J.L., Burguera M., and Hoebel B.G. Chronic lithium administration enhances serotonin release in the lateral hypothalamus but not in the hippocampus in rats. A microdialysis study. J. Neural Transm. Gen. Sect. 82 (1990) 31-41
3. Bauer M., and Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J. Clin. Psychopharmacol. 19 (1999) 427-434
4. Bauer M., Forsthoff A., Baethge C., Adli M., Berghöfer A., Döpfmer S., and Bschor T. Lithium augmentation therapy in refractory depression-update 2002. Eur. Arch. Psychiatry Clin. Neurosci. 253 (2003) 132-139
5. Burgess S., Geddes J., Hawton K., Townsend E., Jamison K., and Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst. Rev. (2001) CD003013
6. Cipriani A., Pretty H., Hawton K., and Geddes J.R. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am. J. Psychiatry 162 (2005) 1805-1819
7. Cordeiro M.L., Gundersen C.B., and Umbach J.A. Lithium ions modulate the expression of VMAT2 in rat brain. Brain Res. 953 (2002) 189-194
8. Cowen P.J., McCance S.L., Cohen P.R., and Julier D.L. Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression. Psychopharmacology (Berl.) 99 (1989) 230-232
9. Cowen P.J., McCance S.L., Ware C.J., Cohen P.R., Chalmers J.S., and Julier D.L. Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome. Br. J. Psychiatry 159 (1991) 341-346
10. Côté F., Thévenot E., Fligny C., Fromes Y., Darmon M., Ripoche M.A., Bayard E., Hanoun N., Saurini F., Lechat P., Dandolo L., Hamon M., Mallet J., and Vodjdani G. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13525-13530
11. de Montigny C., Grunberg F., Mayer A., and Deschenes J.P. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br. J. Psychiatry 138 (1981) 252-256
12. de Montigny C., Elie R., and Caille G. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study. Am. J. Psychiatry 142 (1985) 220-223
13. Gitlin M. Treatment-resistant bipolar disorder. Mol. Psychiatry 11 (2006) 227-240
14. Guzzetta F., Tondo L., Centorrino F., and Baldessarini R.J. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J. Clin. Psychiatry 68 (2007) 380-383
15. Ho A.K., Loh H.H., Craves F., Hitzemann R.J., and Gershon S. The effect of prolonged lithium treatment on the synthesis rate and turnover of monoamines in brain regions of rats. Eur. J. Pharmacol. 10 (1970) 72-78
16. Höltje M., von Jagow B., Pahner I., Lautenschlager M., Hörtnagl H., Nürnberg B., Jahn R., and Ahnert-Hilger G. The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2). J. Neurosci. 20 (2000) 2131-2141
17. Höltje M., Winter S., Walther D., Pahner I., Hörtnagl H., Ottersen O.P., Bader M., and Ahnert-Hilger G. The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse platelets. Evidence for autoregulation of vesicular transmitter uptake. J. Biol. Chem. 278 (2003) 15850-15858
18. Jéquier E., Lovenberg W., and Sjoerdsma A. Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol. Pharmacol. 3 (1967) 274-278
19. Kloiber, S., Kohli, M.A., Brueckl, T., Ripke, S., Ising, M., Uhr, M., Menke, A., Unschuld, P.G., Horstmann, S., Salyakina, D., Muller-Myhsok, B., Binder, E.B., Holsboer, F. and Lucae S., in press. Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Mol Psychiatry.
20. Knapp S., and Mandell A.J. Short- and long-term lithium administration: effects on the brain's serotonergic biosynthetic systems. Science 180 (1973) 645-646
21. Knapp S., and Mandell A.J. Effects of lithium chloride on parameters of biosynthetic capacity for 5-hydroxytryptamine in rat brain. J. Pharmacol. Exp. Ther. 193 (1975) 812-823
22. Kofman O., and Patishi Y. Interactions of lithium and drugs that affect signal transduction on behaviour in rats. Eur. Neuropsychopharmacol. 9 (1999) 385-397
23. Koh J.Y., and Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20 (1987) 83-90
24. Lautenschlager M., Höltje M., von Jagow B., Veh R.W., Harms C., Bergk A., Dirnagl U., Ahnert-Hilger G., and Hörtnagel H. Serotonin uptake and release mechanisms in developing cultures of rat embryonic raphe neurons: age- and region-specific differences. Neuroscience 99 (2000) 519-527
25. McElroy S.L., and Keck Jr. P.E. Pharmacologic agents for the treatment of acute bipolar mania. Biol. Psychiatry 48 (2000) 539-557
26. Mørk A. Effects of lithium treatment on extracellular serotonin levels in the dorsal hippocampus and wet-dog shakes in the rat. Eur. Neuropsychopharmacol. 8 (1998) 267-272
27. Muraki I., Inoue T., Hashimoto S., Izumi T., Ito K., and Koyama T. Effects of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex. J. Neurochem 76 (2001) 490-497
28. Ohman R., and Spigset O. Serotonin syndrome induced by fluvoxamine-lithium interaction. Pharmacopsychiatry 26 (1993) 263-264
29. Patel P.D., Pontrello C., and Burke S. Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland. Biol. Psychiatry. 55 (2004) 428-433
30. Pearce J.M., Lyon M., and Komoroski R.A. Localized 7Li MR spectroscopy: in vivo brain and serum concentrations in the rat. Magn. Reson. Med. 52 (2004) 1087-1092
31. Price L.H., Charney D.S., Delgado P.L., Goodman W.K., Krystal J.H., Woods S.W., and Heninger G.R. Clinical studies of 5-HT function using i.v. l-tryptophan. Prog. Neuropsychopharmacol. Biol. Psychiatry 14 (1990) 459-472
32. Rind H.B., Russo A.F., and Whittemore S.R. Developmental regulation of tryptophan hydroxylase messenger RNA expression and enzyme activity in the raphe and its target fields. Neuroscience 101 (2000) 665-677
33. Scheuch K., Lautenschlager M., Grohmann M., Stahlberg S., Kirchheiner J., Zill P., Heinz A., Walther D.J., and Priller J. Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons. Biol. Psychiatry 62 (2007) 1288-1294
34. Shorter E. The history of lithium therapy. Bipolar Disord. 11 Suppl. 2 (2009) 4-9
35. Stachowiak M.K., Stricker E.M., Jaboby J.H., and Zigmond M.J. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem. Pharmacol. 35 (1986) 1241-1248
36. Sternbach H. The serotonin syndrome. Am. J. Psychiatry 148 (1991) 705-713
37. Tondo L., Jamison K.R., and Baldessarini R.J. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann. N. Y. Acad. Sci. 836 (1997) 339-351
38. Treiser S.L., Cascio C.S., O'Donohue T.L., Thoa N.B., Jacobowitz D.M., and Kellar K.J. Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213 (1981) 1529-1531
39. Walther D.J., and Bader M. A unique central tryptophan hydroxylase isoform. Biochem. Pharmacol. 66 (2003) 1673-1680
40. Walther D.J., Peter J.U., Bashammakh S., Hörtnagl H., Voits M., Fink H., and Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299 (2003) 76
41. Wegener G., Linnet K., Rosenberg R., and Mørk A. The effect of acute citalopram on extracellular 5-HT levels is not augmented by lithium: an in vivo microdialysis study. Brain Res. 871 (2000) 338-342
42. Whitaker J.F. A general colorimetric procedure for the estimation of enzymes which are linked to the NADH-NAD+ system. Clin. Chim. Acta 24 (1969) 23-37
43. Zhou Z., Roy A., Lipsky R., Kuchipudi K., Zhu G., Taubman J., Enoch M.A., Virkkunen M., and Goldman D. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch. Gen. Psychiatry 62 (2005) 1109-1118
44. Zill P., Büttner A., Eisenmenger W., Möller H.J., Ackenheil M., and Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. J. Psychiatr. Res. 41 (2007) 168-173